KRTX - Karuna Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRTX is currently covered by 17 analysts with an average price target of $370.82. This is a potential upside of $40.99 (12.43%) from yesterday's end of day stock price of $329.83.

Karuna Therapeutics's activity chart (see below) currently has 97 price targets and 104 ratings on display. The stock rating distribution of KRTX is 80.43% BUY and 19.57% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.46% with an average time for these price targets to be met of 196.71 days.

Highest price target for KRTX is $330, Lowest price target is $225, average price target is $370.82.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 11-Mar-2024. First documented stock forecast 23-Jul-2019.

Currently out of the existing stock ratings of KRTX, 37 are a BUY (80.43%), 9 are a HOLD (19.57%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$330

$0.17 (0.05%)

$330

7 months 21 days ago
(11-Mar-2024)

13/15 (86.67%)

$10.81 (3.39%)

281

Hold

$330

$0.17 (0.05%)

$330

8 months 12 days ago
(20-Feb-2024)

2/4 (50%)

$11.41 (3.58%)

86

Hold

$245

$-84.83 (-25.72%)

$245

9 months 6 days ago
(26-Jan-2024)

12/13 (92.31%)

$-69 (-21.97%)

168

Buy

$295

$-34.83 (-10.56%)

$280

10 months 10 days ago
(22-Dec-2023)

2/3 (66.67%)

$-22.85 (-7.19%)

148

Buy

$330

$0.17 (0.05%)

$280

10 months 10 days ago
(22-Dec-2023)

5/6 (83.33%)

$12.15 (3.82%)

278

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRTX (Karuna Therapeutics) average time for price targets to be met?

On average it took 196.71 days on average for the stock forecasts to be realized with a an average price target met ratio 91.46

Which analyst has the current highest performing score on KRTX (Karuna Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on KRTX (Karuna Therapeutics)?

Raghuram Selvaraju has 3 price targets and 18 ratings on KRTX

Which analyst is the currently most bullish on KRTX (Karuna Therapeutics)?

Mohit Bansal with highest potential upside - $55.91

Which analyst is the currently most reserved on KRTX (Karuna Therapeutics)?

Chris Howerton with lowest potential downside - -$146.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?